{"id":"W2045145402","doi":"10.1002/cam4.263","title":"A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre","funders":"Merck","keywords":"Clinical endpoint; Medicine; Pharmacodynamics; Colorectal cancer; Response Evaluation Criteria in Solid Tumors; Internal medicine; Standardized uptake value; Chemotherapy; Cancer; Insulin-like growth factor; Progressive disease; Gastroenterology; Phases of clinical research; Oncology; Randomized controlled trial; Urology; Nuclear medicine; Pharmacokinetics; Positron emission tomography; Receptor; Growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005066959,0.0005757987,0.002019444,0.0003271531,0.0001884,0.000009804365,0.0003835981,0.0001862775,0.0004955133],"category_scores_gemma":[0.0007492349,0.0003189857,0.0001527407,0.00135254,0.0005592012,0.000203027,0.0001343831,0.0006942546,0.000005344575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000319918,"about_ca_system_score_gemma":0.0004722999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001774331,"about_ca_topic_score_gemma":0.0002264637,"domain_scores_codex":[0.9960664,0.0003360555,0.001106168,0.0007256484,0.001145271,0.0006204732],"domain_scores_gemma":[0.9973443,0.0002711144,0.0006274454,0.0005668728,0.0008719664,0.0003183265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2031563,0.004410526,0.7611176,0.000266001,0.0007759904,0.00001070585,0.007267362,0.00004795683,0.01333637,0.00004833368,0.001892008,0.007670803],"study_design_scores_gemma":[0.5319754,0.01375325,0.446959,0.001028024,0.0006575403,0.000002627811,0.0005777506,0.0002432078,0.003057404,0.00001494857,0.001291801,0.0004390744],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916167,0.001552503,0.0000224612,0.0009651132,0.001865816,0.003558378,0.00007429842,0.00006082853,0.0002838697],"genre_scores_gemma":[0.9976217,0.0006910892,0.00006036635,0.0006160617,0.0004225115,0.0002537881,0.0001065713,0.00008346348,0.0001445226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3288191,"threshold_uncertainty_score":0.9999262,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01205984776200842,"score_gpt":0.295407696784758,"score_spread":0.2833478490227496,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}